Kristin VanderPas

Partner
Full contact info

Experience

Neumora Therapeutics – $250.1 Million IPO

September 15, 2023

Cooley advised the underwriters on the $250.1 million initial public offering of Neumora Therapeutics, a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed.

Read more

Related contacts

Charlie Kim
Partner, San Diego
Kristin VanderPas
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Denny Won
Partner, San Francisco
Grady Chang
Associate, Los Angeles Santa Monica
Madison (JJ) Meng
Associate, San Francisco
Kyle Huh
Associate, Palo Alto
Peter A. Haddad
Associate, San Diego
Heidi Ausman
Senior Paralegal, San Diego
Lila Hope
Partner, Palo Alto
Natasha Leskovsek
Of Counsel, Washington DC
Mika Reiner Mayer
Partner, Palo Alto
Barbara Mirza
Partner, Los Angeles Santa Monica
Phil Mitchell
Partner, New York
Jennifer Raab
Special Counsel, Palo Alto
Madhuri Roy
Partner, Palo Alto
Erica Russell
Associate, San Francisco
Randy Sabett
Special Counsel, Washington DC
Jennifer Shanley
Special Counsel, New York
Karen Tsai
Special Counsel, Washington DC
Francis Wheeler
Partner, Colorado
Mark Windfeld-Hansen
Senior Counsel, Palo Alto

Related Practices & Industries

Apogee Therapeutics Announces Upsized $345.1 Million IPO

July 18, 2023

Cooley advised the underwriters in the upsized $345.1 million initial public offering of Apogee Therapeutics, a biotechnology company.

Read more

Related contacts

Charlie Kim
Partner, San Diego
Div Gupta
Partner, New York
Kristin VanderPas
Partner, San Francisco
Madhuri Roy
Partner, Palo Alto
Stephanie Gentile
Partner, New York
Geoffrey Spolyar
Partner, Boston
Phil Mitchell
Partner, New York
Francis Wheeler
Partner, Colorado
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Randy Sabett
Special Counsel, Washington DC
Natasha Leskovsek
Of Counsel, Washington DC
Rebecca Ross
Special Counsel, Washington DC
Jennifer Shanley
Special Counsel, New York
Madison (JJ) Meng
Associate, San Francisco
Megan Drill
Associate, San Diego
Alessandra Murata
Partner, Palo Alto
Darah Protas
Associate, Washington DC
Mike Lam
Associate, Los Angeles Santa Monica
David Dalton
Associate, Los Angeles Santa Monica
Peter A. Haddad
Associate, San Diego

Related Practices & Industries

IGM Biosciences – $97.5 Million Follow-on Offering and Concurrent Private Placement

June 22, 2023

Cooley advised the underwriters in IGM Biosciences’ $97.5 million public offering of 9,000,000 shares of non-voting common stock and 3,187,500 shares of voting common stock, each at the public offering price of $8.00 per share, as well as a $22.5 million concurrent private placement. IGM is a clinical-stage biotechnology company committed to developing and delivering a new class of medicines to treat patients with cancer, autoimmune and inflammatory diseases, and infectious diseases. Denny Won, Kristin VanderPas and Charlie Kim led the Cooley team.

Related contacts

Denny Won
Partner, San Francisco
Kristin VanderPas
Partner, San Francisco
Charlie Kim
Partner, San Diego
Christine Turner
Associate, Colorado
Mike Lam
Associate, Los Angeles Santa Monica
Ron Metzger
Paralegal Specialist, San Francisco

Related Practices & Industries

Lavoro to Become Publicly Traded Through Business Combination With TPB Acquisition Corporation I

April 24, 2023

Cooley advised TPB Acquisition Corporation I, a special purpose acquisition company sponsored by The Production Board, in its business combination agreement that will result in Lavoro Limited, a leading agricultural inputs retailer in Latin America, becoming a US publicly listed company with an implied initial enterprise value of approximately $1.2 billion.

Read more

Related contacts

Garth Angelo Osterman
Partner, San Francisco
Rachel Proffitt
Partner, San Francisco
Peter Byrne
Partner, New York
Kristin VanderPas
Partner, San Francisco
Michelle Peleg
Associate, San Francisco
Sarah Curry
Associate, New York
Jesse Schulman
Associate, Washington DC
Wesley Dietrich
Associate, Washington DC
Yoana Setzer
Associate, New York
Aaron Pomeroy
Partner, Colorado
Courtney M.W. Tygesson
Partner, Chicago
Todd Gluth
Partner, San Diego
Calvin Lee
Associate, New York
Rick Jantz
Associate, Los Angeles Santa Monica
Jill Simon
Senior Paralegal, New York

Related Practices & Industries

Erasca – $100 Million Follow-on Offering

January 9, 2023

Cooley advised the underwriters in Erasca’s $100 million follow-on offering of 15,384,616 shares of common stock at a public offering price of $6.50 per share. Erasca is a clinical-stage biopharmaceutical company discovering, developing and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Partners Charlie Kim, Kristin VanderPas and Denny Won led the Cooley team.

Related contacts

Charlie Kim
Partner, San Diego
Kristin VanderPas
Partner, San Francisco
Denny Won
Partner, San Francisco
Mike Lam
Associate, Los Angeles Santa Monica
Julia Gage
Associate, San Francisco

Related Practices & Industries

View more

Rankings & accolades

Chambers USA: Capital Markets: Debt & Equity – California (2021 – 2023)

Chambers USA: Capital Markets: Debt & Equity: Western United States – Nationwide (2021 – 2023)

Daily Journal: Top 40 Under 40 (2019)

Kristin VanderPas has a strong client base of leading investment banks and companies in the tech and life sciences sectors.

Chambers USA 2022